GTS Securities’s Novo Nordisk A/S (B Shares) ADRhedged NVOH Stock Holding History

GTS Securities’s Portfolio NVOH Stock Details NVOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,858	Closed	-$315K	–	1691
2025 Q1	$315K	Buy	+7,858	New	+$377K	0.01%	927

Other funds holding NVOH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities's NVOH Position: Q2 2025 in Review

GTS Securities sold out of Novo Nordisk A/S (B Shares) ADRhedged (NVOH) in Q2 2025, closing a stake of 7,858 shares — an estimated $315K sold.

GTS Securities first reported a position in NVOH in Q1 2025 and held it in 1 quarter. The position peaked at $315K in Q1 2025. 1 fund tracked by Wall St. Rank holds NVOH as of Q2 2025.

GTS Securities reported no remaining Novo Nordisk A/S (B Shares) ADRhedged position as of Q2 2025 after selling out during the quarter.
GTS Securities sold 7,858 Novo Nordisk A/S (B Shares) ADRhedged shares in Q2 2025, an estimated $315K.
GTS Securities first reported a position in Novo Nordisk A/S (B Shares) ADRhedged in Q1 2025 and held it in 1 quarter.
GTS Securities's Novo Nordisk A/S (B Shares) ADRhedged position peaked at $315K in Q1 2025.
1 fund tracked by Wall St. Rank held Novo Nordisk A/S (B Shares) ADRhedged as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.